<?xml version="1.0" encoding="UTF-8"?>
<!-- Ce plan de site a été généré dynamiquement le août 12, 2026 à 11:52 pm par All in One SEO v4.9.9 - l’extension SEO originale pour WordPress. -->

<?xml-stylesheet type="text/xsl" href="https://www.isrec.ch/default-sitemap.xsl"?>

<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
	<channel>
		<title>Fondation ISREC</title>
		<link><![CDATA[https://www.isrec.ch]]></link>
		<description><![CDATA[Fondation ISREC]]></description>
		<lastBuildDate><![CDATA[Wed, 12 Aug 2026 14:02:17 +0000]]></lastBuildDate>
		<docs>https://validator.w3.org/feed/docs/rss2.html</docs>
		<atom:link href="https://www.isrec.ch/sitemap.rss" rel="self" type="application/rss+xml" />
		<ttl><![CDATA[60]]></ttl>

		<item>
			<guid><![CDATA[https://www.isrec.ch/de/sur-srp-2026-agora-stellt-sich-vor-und-bietet-inspiration-fuer-karrieren-in-der-forschung/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/sur-srp-2026-agora-stellt-sich-vor-und-bietet-inspiration-fuer-karrieren-in-der-forschung/]]></link>
			<title>SUR-SRP 2026 – AGORA stellt sich vor und bietet Inspiration für Karrieren in der Forschung</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 14:02:17 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/sur-srp-2026-agora-stellt-sich-vor-und-bietet-inspiration-fuer-karrieren-in-der-forschung-2/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/sur-srp-2026-agora-stellt-sich-vor-und-bietet-inspiration-fuer-karrieren-in-der-forschung-2/]]></link>
			<title>SUR-SRP 2026 – AGORA stellt sich vor und bietet Inspiration für Karrieren in der Forschung</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 14:02:07 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/sur-srp-2026-opening-agoras-doors-and-inspiring-careers-in-research-2/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/sur-srp-2026-opening-agoras-doors-and-inspiring-careers-in-research-2/]]></link>
			<title>SUR-SRP 2026 – Opening AGORA’s doors and inspiring careers in research</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 14:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/sur-srp-2026-faire-decouvrir-agora-inspirer-les-vocations-2/]]></guid>
			<link><![CDATA[https://www.isrec.ch/sur-srp-2026-faire-decouvrir-agora-inspirer-les-vocations-2/]]></link>
			<title>SUR-SRP 2026 &#8211; Faire découvrir AGORA, inspirer les vocations</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 14:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/sur-srp-2026-faire-decouvrir-agora-inspirer-les-vocations/]]></guid>
			<link><![CDATA[https://www.isrec.ch/sur-srp-2026-faire-decouvrir-agora-inspirer-les-vocations/]]></link>
			<title>SUR-SRP 2026 &#8211; Faire découvrir AGORA, inspirer les vocations</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 14:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/sur-srp-2026-opening-agoras-doors-and-inspiring-careers-in-research/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/sur-srp-2026-opening-agoras-doors-and-inspiring-careers-in-research/]]></link>
			<title>SUR-SRP 2026 – Opening AGORA’s doors and inspiring careers in research</title>
			<pubDate><![CDATA[Wed, 12 Aug 2026 14:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/]]></guid>
			<link><![CDATA[https://www.isrec.ch/]]></link>
			<title>Accueil</title>
			<pubDate><![CDATA[Tue, 07 Jan 2025 08:20:41 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/die-rolle-naturlicher-killerzellen-im-kutanen-t-zell-lymphom-pathophysiologische-mechanismen-und-klinische-bedeutung/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/die-rolle-naturlicher-killerzellen-im-kutanen-t-zell-lymphom-pathophysiologische-mechanismen-und-klinische-bedeutung/]]></link>
			<title>Christoph Iselin, MD-Phd im Labor von Prof. Emmanuella Guenova (UNIL) &#8211; (Kutanes Lymphom)</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 13:07:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/le-role-des-cellules-tueuses-naturelles-dans-le-lymphome-cutane-a-cellules-t-mecanismes-pathophysiologiques-et-implications-cliniques/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/le-role-des-cellules-tueuses-naturelles-dans-le-lymphome-cutane-a-cellules-t-mecanismes-pathophysiologiques-et-implications-cliniques/]]></link>
			<title>Christoph Iselin, MD-Phd dans le laboratoire de la Prof. Emmanuella Guenova (UNIL) &#8211; (Lymphome cutané)</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 13:06:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/die-stiftung/dokumentation/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/die-stiftung/dokumentation/]]></link>
			<title>Dokumentation</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 07:52:06 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/the-foundation/documentation/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/the-foundation/documentation/]]></link>
			<title>Documentation</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 07:51:45 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/la-fondation/documentation/]]></guid>
			<link><![CDATA[https://www.isrec.ch/la-fondation/documentation/]]></link>
			<title>Documentation</title>
			<pubDate><![CDATA[Mon, 10 Aug 2026 07:51:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/flipbook/rapport-annuel-2025-en/]]></guid>
			<link><![CDATA[https://www.isrec.ch/flipbook/rapport-annuel-2025-en/]]></link>
			<title>Rapport annuel 2025 &#8211; EN</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 09:27:30 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/flipbook/rapport-annuel-2025-de/]]></guid>
			<link><![CDATA[https://www.isrec.ch/flipbook/rapport-annuel-2025-de/]]></link>
			<title>Rapport annuel 2025 &#8211; DE</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 09:26:59 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/flipbook/rapport-annuel-2025-fr/]]></guid>
			<link><![CDATA[https://www.isrec.ch/flipbook/rapport-annuel-2025-fr/]]></link>
			<title>Rapport annuel 2025 &#8211; FR</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 09:26:21 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/die-forschung/translationale-forschung/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/die-forschung/translationale-forschung/]]></link>
			<title>Projekte</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 08:14:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/eierstockkrebs-prof-denarda-dangaj-unil/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/eierstockkrebs-prof-denarda-dangaj-unil/]]></link>
			<title>&lt;strong&gt;Eierstockkrebs&lt;/strong&gt; – Prof. Denarda Dangaj (UNIL)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 08:01:47 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/cancer-de-lovaire-prof-denarda-dangaj-unil/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/cancer-de-lovaire-prof-denarda-dangaj-unil/]]></link>
			<title>&lt;strong&gt;Cancer de l’ovaire&lt;/strong&gt; – Prof. Denarda Dangaj (UNIL)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 08:01:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/the-research/translational-research/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/the-research/translational-research/]]></link>
			<title>Projects</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:56:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/la-microscopie-a-expansion-en-super-resolution-pour-assurer-la-precision-et-la-securite-des-therapies-a-base-de-lymphocytes-t-modifies/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/la-microscopie-a-expansion-en-super-resolution-pour-assurer-la-precision-et-la-securite-des-therapies-a-base-de-lymphocytes-t-modifies/]]></link>
			<title>&lt;strong&gt;Microscopie en immuno-oncologie translationnelle&lt;/strong&gt; &#8211; Dre Virginie Hamel (UNIGE) et Dre Benita Wolf (CHUV)</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 11:36:26 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/annual-report-2025/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/annual-report-2025/]]></link>
			<title>Annual Report 2025</title>
			<pubDate><![CDATA[Tue, 16 Jun 2026 09:20:05 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/rapport-annuel-2025/]]></guid>
			<link><![CDATA[https://www.isrec.ch/rapport-annuel-2025/]]></link>
			<title>Rapport annuel 2025</title>
			<pubDate><![CDATA[Tue, 16 Jun 2026 09:18:38 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/la-recherche/projets/]]></guid>
			<link><![CDATA[https://www.isrec.ch/la-recherche/projets/]]></link>
			<title>Projets</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:55:28 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/immuntherapie-fur-rezidivierte-refraktare-akute-pra-b-zell-lymphoblastische-leukamie-bei-kindern-und-jungen-erwachsenen-erstellung-einer-klinischen-studie-mit-car-t-lymphozyten/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/immuntherapie-fur-rezidivierte-refraktare-akute-pra-b-zell-lymphoblastische-leukamie-bei-kindern-und-jungen-erwachsenen-erstellung-einer-klinischen-studie-mit-car-t-lymphozyten/]]></link>
			<title>&lt;strong&gt;Immuntherapie bei Kindern (Lymphom)&lt;/strong&gt; &#8211; Dr. Francesco Ceppi (CHUV) und Prof. Li Tang (EPFL)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:52:33 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/fiamma-therapie-par-lymphocytes-t-a-recepteur-antigenique-chimerique-pour-enfants-et-adultes-atteints-de-leucemie-myeloide-aigue-en-rechute/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/fiamma-therapie-par-lymphocytes-t-a-recepteur-antigenique-chimerique-pour-enfants-et-adultes-atteints-de-leucemie-myeloide-aigue-en-rechute/]]></link>
			<title>&lt;strong&gt;FIAMMA : Immunothérapie dans le traitement de leucémie myéloïde&lt;/strong&gt; &#8211; Dr Francesco Ceppi (CHUV) et Prof. Caroline Arber (UNIL/CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:51:02 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/fiamma-chimeric-antigen-receptor-t-cell-therapy-for-children-and-adults-with-relapsed-acute-myeloid-leukemia/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/fiamma-chimeric-antigen-receptor-t-cell-therapy-for-children-and-adults-with-relapsed-acute-myeloid-leukemia/]]></link>
			<title>&lt;strong&gt;FIAMMA: Immunotherapy for the treatment of myeloid leukemia&lt;/strong&gt; &#8211; Dr. Francesco Ceppi (CHUV) and Prof. Caroline Arber (UNIL/CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:50:52 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/fiamma-car-t-zell-therapie-fur-kinder-und-erwachsene-bei-einem-ruckfall-der-akuten-myeloischen-leukamie/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/fiamma-car-t-zell-therapie-fur-kinder-und-erwachsene-bei-einem-ruckfall-der-akuten-myeloischen-leukamie/]]></link>
			<title>&lt;strong&gt;FIAMMA: Immuntherapie zur Behandlung der myeloischen Leukämie&lt;/strong&gt; &#8211; Dr. Francesco Ceppi (CHUV) und Prof. Caroline Arber (UNIL/CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:50:37 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/multisystem-krebsbiologie-prof-holger-auner-chuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/multisystem-krebsbiologie-prof-holger-auner-chuv/]]></link>
			<title>&lt;strong&gt;Multisystem-Krebsbiologie&lt;/strong&gt; &#8211; Prof. Holger Auner (CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:50:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/biologie-du-cancer-multisystemes-prof-holger-auner-chuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/biologie-du-cancer-multisystemes-prof-holger-auner-chuv/]]></link>
			<title>&lt;strong&gt;Biologie du cancer multisystèmes&lt;/strong&gt; – Prof. Holger Auner (CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:49:49 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/multi-system-cancer-biology-prof-holger-auner-chuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/multi-system-cancer-biology-prof-holger-auner-chuv/]]></link>
			<title>&lt;strong&gt;Multisystem cancer biology&lt;/strong&gt; &#8211; Prof. Holger Auner (CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:49:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/blutkrebs-prof-riether-unibe-dr-wehrli-inselspital/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/blutkrebs-prof-riether-unibe-dr-wehrli-inselspital/]]></link>
			<title>&lt;strong&gt;Blutkrebs&lt;/strong&gt; &#8211; Prof. Carsten Riether (UNIBE) und Dr. Marc Wehrli (INSEL)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:48:44 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/cancer-du-sang-prof-riether-unibe-dr-wehrli-inselspital/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/cancer-du-sang-prof-riether-unibe-dr-wehrli-inselspital/]]></link>
			<title>&lt;strong&gt;Cancer du sang&lt;/strong&gt; &#8211; Prof. Carsten Riether (UNIBE) et Dr Marc Wehrli (INSEL)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:48:29 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/transcriptomique-spatiale-dans-le-melanome-dr-krisztian-homicsko-chuv-prof-raphael-gottardo-unil-etdr-pierre-moulin-chuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/transcriptomique-spatiale-dans-le-melanome-dr-krisztian-homicsko-chuv-prof-raphael-gottardo-unil-etdr-pierre-moulin-chuv/]]></link>
			<title>&lt;strong&gt;Transcriptomique spatiale dans le mélanome&lt;/strong&gt; &#8211; Dr Krisztian Homicsko (CHUV), Prof. Raphael Gottardo (UNIL) et Dr Pierre Moulin (CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:47:46 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/spatial-transcriptomics-in-melanoma-dr-krisztian-homicsko-chuv-prof-raphael-gottardo-unil-and-dr-pierre-moulin-chuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/spatial-transcriptomics-in-melanoma-dr-krisztian-homicsko-chuv-prof-raphael-gottardo-unil-and-dr-pierre-moulin-chuv/]]></link>
			<title>&lt;strong&gt;Spatial transcriptomics in melanoma&lt;/strong&gt; &#8211; Dr. Krisztian Homicsko (CHUV), Prof. Raphael Gottardo (UNIL) and Dr. Pierre Moulin (CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:47:15 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/raeumliche-transkriptomik-beim-melanom-dr-krisztian-homicsko-chuv-prof-raphael-gottardo-unil-unddr-pierre-moulin-chuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/raeumliche-transkriptomik-beim-melanom-dr-krisztian-homicsko-chuv-prof-raphael-gottardo-unil-unddr-pierre-moulin-chuv/]]></link>
			<title>&lt;strong&gt;Räumliche Transkriptomik beim Melanom&lt;/strong&gt; &#8211; Dr. Krisztian Homicsko (CHUV), Prof. Raphael Gottardo (UNIL) und Dr. Pierre Moulin (CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:46:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/super-resolution-expansion-microscopy-for-precision-and-safety-of-engineered-t-cell-therapy/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/super-resolution-expansion-microscopy-for-precision-and-safety-of-engineered-t-cell-therapy/]]></link>
			<title>&lt;strong&gt;Microscopy in translational immuno-oncology&lt;/strong&gt; &#8211; Dr. Virginie Hamel (UNIGE) and Dr. Benita Wolf (CHUV)</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 11:35:54 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/verbesserung-der-wirksamkeit-von-psma-gerichteten-radioligandentherapien-mithilfevon-radiosensibilisierungsstrategien-und-kombinationsbehandlungen-helene-koch-unilchuv/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/verbesserung-der-wirksamkeit-von-psma-gerichteten-radioligandentherapien-mithilfevon-radiosensibilisierungsstrategien-und-kombinationsbehandlungen-helene-koch-unilchuv/]]></link>
			<title>&lt;strong&gt;Translationale radiopharmazeutische Wissenschaften&lt;/strong&gt; &#8211; Prof. Margret Schottelius (CHUV) und Hélène Koch (UNIL/CHUV)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:46:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/jahresbericht-2025/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/jahresbericht-2025/]]></link>
			<title>Jahresbericht 2025</title>
			<pubDate><![CDATA[Tue, 04 Aug 2026 10:55:22 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/virtual-patient-platform-prof-charlotte-bunne-epfl-and-prof-olivier-michielin-hug/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/virtual-patient-platform-prof-charlotte-bunne-epfl-and-prof-olivier-michielin-hug/]]></link>
			<title>&lt;strong&gt;Virtual Patient Platform&lt;/strong&gt; &#8211; Prof. Charlotte Bunne (EPFL) and Prof. Olivier Michielin (HUG)</title>
			<pubDate><![CDATA[Mon, 03 Aug 2026 11:30:50 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/eine-phase-i-klinische-studie-zur-bewertung-der-prophylaktischen-infusion-von-spender-cd45ra-negativen-gedachtnis-effektor-t-zellen-bei-patienten-denen-hamatopoetische-stammzellen-eines-haploidenti/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/eine-phase-i-klinische-studie-zur-bewertung-der-prophylaktischen-infusion-von-spender-cd45ra-negativen-gedachtnis-effektor-t-zellen-bei-patienten-denen-hamatopoetische-stammzellen-eines-haploidenti/]]></link>
			<title>&lt;strong&gt;Lymphozyteninfusion nach Zelltransplantation&lt;/strong&gt; &#8211; Dr. Anne-Claire Mamez (HUG)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:53:23 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/transfer-von-cd4-t-zellen-mit-modifiziertem-tcr-zur-optimierung-der-krebsimmuntherapie-bei-erwachsenen-und-padiatrischen-patienten/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/transfer-von-cd4-t-zellen-mit-modifiziertem-tcr-zur-optimierung-der-krebsimmuntherapie-bei-erwachsenen-und-padiatrischen-patienten/]]></link>
			<title>&lt;strong&gt;Kinderleukämie&lt;/strong&gt; &#8211; Prof. Camilla Jandus (UNIGE), Dr. Francesco Ceppi und Prof. George Coukos (CHUV)</title>
			<pubDate><![CDATA[Thu, 28 May 2026 13:44:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/ovarian-cancer-prof-denarda-dangaj-unil/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/ovarian-cancer-prof-denarda-dangaj-unil/]]></link>
			<title>&lt;strong&gt;Ovarian Cancer&lt;/strong&gt; – Prof. Denarda Dangaj (UNIL)</title>
			<pubDate><![CDATA[Sat, 11 Jul 2026 05:31:35 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/a-phase-i-clinical-trial-assessing-prophylactic-infusion-of-donor-cd45ra-negative-memory-effector-t-cells-into-patients-transplanted-with-hematopoietic-stem-cells-from-haploidentical-donors-after-re/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/a-phase-i-clinical-trial-assessing-prophylactic-infusion-of-donor-cd45ra-negative-memory-effector-t-cells-into-patients-transplanted-with-hematopoietic-stem-cells-from-haploidentical-donors-after-re/]]></link>
			<title>&lt;strong&gt;Lymphocyte infusion following cell transplantation&lt;/strong&gt; &#8211; Dr. Anne-Claire Mamez (HUG)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:53:11 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/seit-62-jahren-dieselbe-ueberzeugung/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/seit-62-jahren-dieselbe-ueberzeugung/]]></link>
			<title>Seit 62 Jahren dieselbe Überzeugung</title>
			<pubDate><![CDATA[Thu, 18 Jun 2026 07:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/immunotherapie-pour-la-leucemie-aigue-lymphoblastique-a-precurseurs-b-recidivante-refractaire-chez-lenfant-et-le-jeune-adulte-developpement-dun-essai-clinique-avec-lymphocytes-t-ca/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/immunotherapie-pour-la-leucemie-aigue-lymphoblastique-a-precurseurs-b-recidivante-refractaire-chez-lenfant-et-le-jeune-adulte-developpement-dun-essai-clinique-avec-lymphocytes-t-ca/]]></link>
			<title>&lt;strong&gt;Immunothérapie pédiatrique (lymphome)&lt;/strong&gt; &#8211; Dr Francesco Ceppi (CHUV) et Prof. Li Tang (EPFL)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:52:18 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/62-years-and-still-the-same-conviction/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/62-years-and-still-the-same-conviction/]]></link>
			<title>62 years and still the same conviction</title>
			<pubDate><![CDATA[Thu, 18 Jun 2026 07:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/62-ans-et-toujours-la-meme-conviction/]]></guid>
			<link><![CDATA[https://www.isrec.ch/62-ans-et-toujours-la-meme-conviction/]]></link>
			<title>62 ans, et toujours la même conviction</title>
			<pubDate><![CDATA[Thu, 18 Jun 2026 07:00:00 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/recherche/plateforme-virtual-patient-prof-charlotte-bunne-epfl-et-prof-olivier-michielin-hug/]]></guid>
			<link><![CDATA[https://www.isrec.ch/recherche/plateforme-virtual-patient-prof-charlotte-bunne-epfl-et-prof-olivier-michielin-hug/]]></link>
			<title>&lt;strong&gt;Plateforme Virtual Patient&lt;/strong&gt; &#8211; Prof. Charlotte Bunne (EPFL) et Prof. Olivier Michielin (HUG)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:51:51 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/en/research/tcr-engineered-cd4-t-cell-transfer-for-optimized-cancer-immunotherapy-in-adult-and-pediatric-patients/]]></guid>
			<link><![CDATA[https://www.isrec.ch/en/research/tcr-engineered-cd4-t-cell-transfer-for-optimized-cancer-immunotherapy-in-adult-and-pediatric-patients/]]></link>
			<title>&lt;strong&gt;Pediatric leukemia&lt;/strong&gt; &#8211; Prof. Camilla Jandus (UNIGE), Dr. Francesco Ceppi and Prof. George Coukos (CHUV)</title>
			<pubDate><![CDATA[Thu, 28 May 2026 13:43:40 +0000]]></pubDate>
		</item>
					<item>
			<guid><![CDATA[https://www.isrec.ch/de/forschung/virtual-patient-plattform-prof-charlotte-bunne-epfl-und-prof-olivier-michielin-hug/]]></guid>
			<link><![CDATA[https://www.isrec.ch/de/forschung/virtual-patient-plattform-prof-charlotte-bunne-epfl-und-prof-olivier-michielin-hug/]]></link>
			<title>&lt;strong&gt;Virtual Patient Plattform&lt;/strong&gt; &#8211; Prof. Charlotte Bunne (EPFL) und Prof. Olivier Michielin (HUG)</title>
			<pubDate><![CDATA[Fri, 07 Aug 2026 07:51:42 +0000]]></pubDate>
		</item>
				</channel>
</rss>
